We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission Application Announcement

10 Feb 2016 07:00

RNS Number : 5304O
Ashley House PLC
10 February 2016
 

10 February 2016

Ashley House plc

("Ashley House" or the "Company")

Admission Application Announcement

The Company announces that, with effect from 8:00 a.m. today, the Company's ordinary shares will commence trading on the ISDX Growth Market under the ticker ASH.

Ashley House will be quoted on the Social Impact segment of the ISDX Growth Market and will remain listed on AIM following admission to ISDX.

 

Ends

Enquiries:

 

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland Limited 0207 220 1666

(Nominated Adviser, Corporate Adviser and broker to Ashley House plc)

Adrian Hadden

Mark Leonard

 

The following information is provided pursuant to the ISDX Growth Market Rules for Issuers:

Company Information

The Company is a leading extra care housing and health property partner working with providers and commissioners in the public, private & community sectors, and which is admitted to trading on AIM. The Company has 25 years of providing innovative approaches in the resourcing, funding, design and development of flexible and efficient social and community health, care and supported living environments.

Details of Directors

The full names of the Directors of the Company and positions are as follows:

Antony Walters, Chief Executive

Antony has a BA in accounting and qualified as a chartered accountant in 1992. He gained an ExecutiveMBA by evening study from Warwick University in 2004. He joined Ashley House in 2010 as FinanceDirector having held various senior executive positions within the Lloyds Pharmacy group, includingleading the corporate acquisitions, property and development teams. Antony spent 15 months in a panEuropean strategic development role based in Germany for Lloyds' parent company Celesio AG.Immediately prior to Ashley House, Antony was managing director of Sapphire Primary CareDevelopments Limited which Ashley House acquired from Lloyds Pharmacy in 2009. Antony wasappointed Chief Executive in October 2014.

Christopher Lyons, Non-Executive Chairman

Christopher has extensive experience in strategic planning, corporate governance, bankingand housing finance. His career spans 35 years, first with Abbey National where he held a number of seniorexecutive positions of increasing importance. He has also led major infrastructure projects such as the branch development programme and creating Cahoot, the internet bank.He then joined the executive Board of Minster Trust Limited, a fully regulated banking institutionleading the development and launch of an affinity based internet banking proposition.Christopher has extensive Non-executive experience chairing amongst others, the Boardof London Strategic Housing and recently as deputy chairman of Network Housing Group wherehe also chaired the Audit and Risk Committee. He holds a Masters degree in Strategic FinancialManagement and is a visiting fellow at Kingston and Durham Business Schools. Christopher hasalso worked with the NHS Commissioning Board authorising the recently formed nationalnetwork of Commissioning Support Units (CSUs), specifically assessing and developing business strategiesand the subsequent appointment of their managing directors. He chaired the advisoryBoard for the NHS Yorkshire and Humberside CSU and is currently a member of the NHS Arden Greater East Midlands CSU Advisory Board.

Stephen Minion, Non-Executive Deputy Chairman

Stephen is a chartered engineer with a long career in design and development of commercial property.Following the award of his degree in engineering he joined the London Borough of Harrow where hegained chartered engineer status. He moved to George Wimpey & Co and learnt his main"stock in trade" as a property developer before starting his own company in 1978. In 1991 heco-founded Ashley House where his specialist knowledge is invaluable in the delivery of the Company'score product and the development of new services. Stephen chairs the Company's RemunerationCommittee and is a Board member of a number of associated companies. 

Jonathan Holmes, Commercial Director

Prior to joining Ashley House in 1998, Jonathan worked in sales and marketing with an emphasis on settingup new ventures. In the 1990s he worked in the City for Thomson Financial Services and latterly the capitalmarkets and Eurobond regulator ISMA. Jonathan leads the Ashley House teams that work with clientsand stakeholders to source, structure and develop our projects. Jonathan is a passionate advocate ofAshley House's ability to use its status as a profit making plc to create social value well in excess of itssize and has led Ashley House's involvement as a Founder Member of the Social Stock Exchange.

Andrew Willetts, Non-executive Director

Andrew has a BA in history from Keble College, Oxford and qualified as a chartered accountant withwhat is now PricewaterhouseCoopers in 1991. He has held senior financial roles in the retail andwholesale sectors, including Waterstones and Hagemeyer (now part of the Rexel group). He joinedLloyds Pharmacy in 2003, becoming finance director in 2007 and public sector and healthcareservices director in 2012, with responsibility for the delivery of pharmacy services and pharmaceuticalsupply into NHS hospitals and other public and private sector organisations. He had Lloyds PharmacyBoard responsibility for Sapphire Primary Care Developments until its sale to Ashley House.Andrew is Chairman of Ashley House's Audit & Risk Committee.

John Moy, Non-executive Director

John has advised and invested in fast-growing companies for over 20 years including a period sittingon the panel of Non-executive directors appointed by 3i plc to their investee companies.In his industrial career he was both a Chartered Engineer and Chartered Management Accountantand was Factory Manager and Financial Controller for Mars Limited and a UK and Northern EuropeFinance Director for Motorola Inc. He was the Finance Director of the successful managementbuy-in of RHP Bearings. John provides strategic financial management skills and experienceto the Board.

Sector Classification

Ashley House will be classified as a Health Care Equipment & Services company on ISDX.

Shareholder Information

Shareholder

Number of Shares

% Shareholding

Pershing Nominees

6,000,000

10.29

Admenta Ltd (Lloyds Pharmacy)

5,493,827

9.42

John Moy (Non-Executive Director)

4,500,000

7.72

Stephen Minion (Non-Executive Deputy Chairman)

4,062,825

6.97

James Moy

3,000,000

5.14

Mrs. G. Mosley (former director)

2,125,518

3.64

Jonathan Holmes (Commercial Director)

2,088,736

3.58

Total Significant Shareholders

27,270,906

46.76

 

The Company operates an equity-settled share option scheme under which it has granted share options to its executive directors and certain senior managers. The options granted are cancelled in the event of the option holder leaving the Company. The options held by directors are set out below:

Director

Exercise price

Number of options

Antony Walters

9.75p

2,200,000

Jonathan Holmes

9.75p

2,000,000

4,200,000

 

The options, which have an exercise price of 9.75p, will not become exercisable unless and until the Company's share price equals or exceeds 37p for a period of at least 90 consecutive workings days and upon exercise is at or above the 37p threshold.

The percentage of securities in public hands (as defined in the ISDX Growth Market Rules for Issuers) is 55.6%. The percentage of securities not in public hands is 44.4%. There are no restrictions on the transfer of Ashley House's securities.

Further Information

Ashley House was admitted to trading on AIM on 15 January 2007; a copy of the admission document dated 12 January 2007 is available on the Company's website, www.ashleyhouseplc.com.

The Company will remain admitted to trading on AIM following admission to ISDX. Its ordinary shares are eligible for CREST settlement. The Company is subject to the UK City Code on Takeovers and Mergers.

Antony Walters, Chief Executive, commented:

"Ashley House is a founder member of the Social Stock Exchange (SSX) and is delighted to take this step to dual list now that SSX has a formal segment on a market. This will operate alongside our existing listing on AIM. Ashley House is a leading extra care housing and health property partner. Through the new listing we look forward to our business being more visible to investors seeking shares in companies with strong social values."

 The directors of Ashley House plc accept responsibility for this announcement.

Registered Address of Applicant

Ashley House plc

Unit 1, Barnes Wallis Court

Wellington Road

Cressex Business Park

High Wycombe

HP12 3PS

Telephone +44 (0)1628 600 340

www.ashleyhouseplc.com

 

Corporate Adviser and Contact Details

WH Ireland Ltd

24 Martin Lane

London

Adrian Hadden / Mark Leonard

Telephone: +44 (0)20 7220 1666

 

- Ends -

For further information please contact: 

Ashley House plc +44 (0) 1628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland Limited (NOMAD & Broker) +44 (0) 207 220 1666

Adrian Hadden

Mark Leonard

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTLMBTMBJMBLF
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.